Form 4 Tracker
Jeremy Bender

Director, CHIEF EXECUTIVE OFFICER · 1 filing · Latest: Apr 23, 2026

Day One Biopharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
DAWN
Jeremy BenderDirector, CHIEF EXECUTIVE OFFICERApr 23, 2026
Disposition
1,799,0310